InvestorsHub Logo
Followers 30
Posts 2470
Boards Moderated 1
Alias Born 05/03/2012

Re: None

Monday, 09/14/2020 5:55:25 PM

Monday, September 14, 2020 5:55:25 PM

Post# of 424558
I will say it again, if management wants any shot at cashing their free shares in the mid to high tens of millions they need to get a few Pharmas to buy 5 to 10 percent of the company on the open market. As investors, they will help these morons navigate the legal/regulatory environment and create a true brand image for Vascepa. Then, one or more can buy the company and in parts might be best. Say, one thinks ROW outside the EU is worth 6 or 7 per share ( includes China and Canada royalties) another might want the EU for $15 per share and another might think that the US and potential V2.0 might be worth $5 to $10. Selling it off by territory might be our best bet. If they would just hire an investment banker we would see some progress towards a final sale. This company and management team is not capable of going it alone or growing the company into something else.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News